2023

Pacific Edge Appoints Glen Costin President APAC

Pacific Edge Appoints Glen Costin President APAC

Pacific Edge (NZX, ASX: PEB) today announces the appointment of Glen Costin into the new role of President Asia Pacific (APAC) to realize the significant potential for the company’s genomic Cxbladder tests in the region.

In the new role Mr Costin is charged with building Pacific Edge’s APAC business unit largely from the ground up. He will drive the strategic and operational direction in the region, which boasts an estimated total addressable market for the company’s Cxbladder bladder cancer diagnostic tests of US$2.2 billion.1

For the last eight years, at the helm of his own company MDL Asia, Mr Costin has assisted small and medium sized medical, diagnostics and life science companies to expand in the Asia Pacific. Over that period, he assisted his clients to grow annual revenues by US$20 million to US$30 million per year. Prior to that he held senior roles with biotechnology research company Abcam, laboratory equipment supplier Bio-Rad Laboratories and BD (Becton Dickinson).

Pacific Edge Chief Executive Dr. Peter Meintjes said: “Glen brings to Pacific Edge a strong regional network in APAC, a strong commercial background, a track record of success in business development and in bringing new technology to market. We are looking forward to working with him to realize the potential of Cxbladder in the Asia Pacific, our next most important market after the US.”

Mr Costin said: “I'm excited to take on the challenge of establishing a market in APAC for Cxbladder. There is a clear gap in the market for bladder cancer biomarkers for hematuria evaluation and surveillance across the various hospitals and laboratory networks in the region.

“While hospital systems are not as developed as some other countries, there are large population centers in the region and a growing appetite for improving healthcare outcomes with advanced genomic testing. I am looking forward to working with Peter and the team to achieve these goals.”

Mr Costin holds a BSc from Macquarie University and an MBA from the Macquarie Graduate School of Management. He started at Pacific Edge on 27 March, and will report to Dr. Meintjes.

An image of Mr Costin can be downloaded via this link.

 

1 Total Addressable Market for APAC (not including China) based on Pacific Edge estimates.

« Back